{"id":"tp-33730","type":"article-newspaper","title":"FDA Expands Ryzumvi’s Approved Uses to Adult Presbyopia","author":"Riza Dagoc","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/regulation/33730","datePublished":"2026-10-17T04:42:18.000Z","dateModified":"2026-10-17T04:42:18.000Z","language":"en","abstract":"The 0.75% phentolamine eye drop was previously approved to reverse drug-induced pupil dilation. In a Phase 3 trial, 27.2% of participants met the near-vision endpoint, compared with 11.5% on placebo.","section":"Regulation","references":[]}